I'rom Group Co Ltd (2372.T)
1,839JPY
7:00am BST
¥10 (+0.55%)
¥1,829
¥1,804
¥1,843
¥1,786
37,700
132,836
¥3,545
¥1,585
Latest Key Developments (Source: Significant Developments)
I'rom Group unit concludes iPS cell generation technology licensing agreement with UK-based Elpis Biomed
Aug 22(Reuters) - I'rom Group Co Ltd <2372.T>:Says its wholly owned unit ID Pharma concluded an iPS cell generation technology licensing agreement with UK-based Elpis Biomed Limited.Under this agreement, Elpis Biomed Limited will pay up-front payment and royalties to ID Pharma . Full Article
I'rom Group signs partnership agreement with China co Beroni Group
Aug 21 (Reuters) - I'rom Group Co Ltd <2372.T>:Says it signed partnership agreement with China company Beroni Group Limited on new business in cell culture and processing fields . Full Article
I'rom Group signs cooperation agreement with DENDRIX on advanced medical business
May 28 (Reuters) - I'rom Group Co Ltd <2372.T>:Says it signs cooperation agreement with DENDRIX Inc. on advanced medical business .Says they will mainly cooperate on cell processing center related contract manufacturing and cell processing technology development . Full Article
I'rom Group unit signs iPS cell tech related license agreement with Q-State Biosciences
Jan 9 (Reuters) - I'rom Group Co Ltd <2372.T>:Says co's wholly owned unit ID Pharma signs iPS cell (induced pluripotent stem cell) technology related license agreement with U.S.-based firm Q-State Biosciences Inc. Full Article
I'rom Group says business and capital alliance with OKWAVE unit
Oct 17 (Reuters) - I'rom Group Co Ltd <2372.T>:Says co signs business and capital alliance agreement with OKWAVE <<<3808.NG>>> unit OKEIOS, which is mainly engaged in medical information handling systems related design, development and sales .Says co plans to acquire shares of OKEIOS. Full Article
Earnings vs. 
Estimates